BACKGROUND: In idiopathic Parkinson's disease (IPD) transcranial sonography (TCS) represents an alternative diagnostic method to verify clinical diagnosis. Although the phenomenon of an increased echogenicity of the Substantia nigra (SN) is well known this method is still not widly used in the diagnostic workup. Until now reliability of this method is still a matter of debate, partly because data only existed from a few laboratories using the same ultrasound machine. Therefore our study was conducted to test the reliability of this method by using a different ultrasound device and examining a large population of control and IPD subjects by two examiners to calculate interobserver reliability. METHOD: In this study echogenicity of SN was examined in 199 IPD patients and 201 control subjects. All individuals underwent a neurological assessment including Perdue pegboard test and Webster gait test. Using a Sonos 5500 ultrasound device area of SN was measured, echogenicity of raphe, red nuclei, thalamus, caudate and lenticular nuclei, width of third and lateral ventricle were documented. RESULTS: We found a highly characteristic enlargement of the SN echogenic signal in IPD. The cut-off value for the SN area was established using a ROC curve with a sensitivity of 95% corresponding to an area of SN of 0.2 cm2 and was found to be equivalent to the cut-off values of other studies using different ultrasound devices. CONCLUSIONS: Our study shows that TCS is a reliable and highly sensitive tool for differentiation of IPD patients from individuals without CNS disorders.
BACKGROUND: In idiopathic Parkinson's disease (IPD) transcranial sonography (TCS) represents an alternative diagnostic method to verify clinical diagnosis. Although the phenomenon of an increased echogenicity of the Substantia nigra (SN) is well known this method is still not widly used in the diagnostic workup. Until now reliability of this method is still a matter of debate, partly because data only existed from a few laboratories using the same ultrasound machine. Therefore our study was conducted to test the reliability of this method by using a different ultrasound device and examining a large population of control and IPD subjects by two examiners to calculate interobserver reliability. METHOD: In this study echogenicity of SN was examined in 199 IPD patients and 201 control subjects. All individuals underwent a neurological assessment including Perdue pegboard test and Webster gait test. Using a Sonos 5500 ultrasound device area of SN was measured, echogenicity of raphe, red nuclei, thalamus, caudate and lenticular nuclei, width of third and lateral ventricle were documented. RESULTS: We found a highly characteristic enlargement of the SN echogenic signal in IPD. The cut-off value for the SN area was established using a ROC curve with a sensitivity of 95% corresponding to an area of SN of 0.2 cm2 and was found to be equivalent to the cut-off values of other studies using different ultrasound devices. CONCLUSIONS: Our study shows that TCS is a reliable and highly sensitive tool for differentiation of IPD patients from individuals without CNS disorders.
Authors: T Postert; B Lack; W Kuhn; M Jergas; J Andrich; B Braun; H Przuntek; R Sprengelmeyer; M Agelink; T Büttner Journal: J Neurol Neurosurg Psychiatry Date: 1999-10 Impact factor: 10.154
Authors: D Berg; G Becker; B Zeiler; O Tucha; E Hofmann; M Preier; P Benz; W Jost; K Reiners; K W Lange Journal: Neurology Date: 1999-09-22 Impact factor: 9.910
Authors: Petra Ruprecht-Dörfler; Daniela Berg; Oliver Tucha; Peter Benz; Michael Meier-Meitinger; Gesine L Alders; Klaus W Lange; Georg Becker Journal: Neuroimage Date: 2003-02 Impact factor: 6.556
Authors: Simon G Parkin; Ralph P Gregory; Richard Scott; Peter Bain; Peter Silburn; Bruce Hall; Richard Boyle; Carole Joint; Tipu Z Aziz Journal: Mov Disord Date: 2002-07 Impact factor: 10.338
Authors: Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz Journal: Neurobiol Dis Date: 2013-10-08 Impact factor: 5.996
Authors: Gabrielle Todd; Miranda Haberfield; Patrick L Faulkner; Caroline Rae; Michael Hayes; Robert A Wilcox; Janet L Taylor; Simon C Gandevia; Jana Godau; Daniela Berg; Olivier Piguet; Kay L Double Journal: J Neural Transm (Vienna) Date: 2014-05-03 Impact factor: 3.575
Authors: Araceli Alonso-Canovas; Jose Luis Lopez-Sendon Moreno; Javier Buisan; Susana Sainz de la Maza; Lucienne Costa-Frossard; Guillermo Garcia-Ribas; Alicia de Felipe-Mimbrera; Maria Consuelo Matute-Lozano; Beatriz Zarza Sanz; Rafael Toledano Delgado; Iñigo Corral; Jaime Masjuan; Juan Carlos Martinez-Castrillo Journal: J Neurol Date: 2018-08-16 Impact factor: 4.849
Authors: Patrizio Prati; A Bignamini; L Coppo; A Naldi; C Comi; R Cantello; G Gusmaroli; U Walter Journal: J Neural Transm (Vienna) Date: 2017-04-27 Impact factor: 3.575
Authors: Angela E P Bouwmans; Annemarie M M Vlaar; Werner H Mess; Alfons Kessels; Wim E J Weber Journal: BMJ Open Date: 2013-04-02 Impact factor: 2.692